
Quotient Limited QTNT
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited ROE 2011-2026 | QTNT
ROE Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 312.05 | 1859.47 | -6148.54 | 562.76 | 353.12 | -72.51 | 3656.9 | 32.23 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3656.9 | -6148.54 | 69.44 |
ROE Vierteljährlich Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 152.07 | 181.38 | 243.77 | 240.86 | 309.43 | -1138.02 | -1642.41 | -1775.74 | -1760.06 | -500.5 | -264.59 | -162.67 | -135.68 | -89.97 | -44.25 | 83.94 | -558.85 | -983.93 | -745.0 | -851.72 | -238.46 | 906.37 | 537.84 | 256.59 | 219.15 | -431.54 | -447.66 | -115.17 | 417.88 | 988.37 | 668.7 | -100.1 | -100.1 | -633.16 | -61.29 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 988.37 | -1775.74 | -216.41 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Sotera Health Company
SHC
|
12.86 | $ 13.28 | -1.96 % | $ 3.77 B | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
Biodesix
BDSX
|
-205.65 | $ 14.59 | -0.07 % | $ 1.89 B | ||
|
Agilent Technologies
A
|
22.45 | $ 110.88 | -2.29 % | $ 33.7 B | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
BioNano Genomics
BNGO
|
-59.42 | $ 1.15 | - | $ 6.26 M | ||
|
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 16.57 | -10.43 % | $ 178 M | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
30.46 | $ 62.48 | -5.47 % | $ 24.4 B | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
-41.08 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 15.62 | -4.64 % | $ 472 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
Guardant Health
GH
|
419.18 | $ 85.04 | -3.47 % | $ 10.7 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 24.15 | -2.23 % | $ 671 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
-4.56 | $ 158.32 | -4.12 % | $ 7.85 B | ||
|
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 196.15 | -1.01 % | $ 21.8 B | ||
|
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 101.83 | -1.21 % | $ 8.4 B | ||
|
DarioHealth Corp.
DRIO
|
-61.41 | $ 8.45 | - | $ 33.7 M | ||
|
Illumina
ILMN
|
-51.54 | $ 117.51 | -5.54 % | $ 18.7 B | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
-302.3 | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
IQVIA Holdings
IQV
|
20.91 | $ 164.58 | -2.85 % | $ 28.3 B | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
-52.72 | $ 8.84 | -3.39 % | $ 1.92 B | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Personalis
PSNL
|
-40.05 | $ 6.4 | -12.64 % | $ 379 M | ||
|
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 266.29 | -0.78 % | $ 22.2 B | ||
|
Senseonics Holdings
SENS
|
-113.21 | $ 6.54 | -0.3 % | $ 273 M | ||
|
Psychemedics Corporation
PMD
|
-62.26 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
-40.56 | $ 26.03 | -1.92 % | $ 33.8 M | ||
|
CareDx, Inc
CDNA
|
-7.05 | $ 16.83 | -3.66 % | $ 897 M | ||
|
Syneos Health
SYNH
|
6.88 | - | - | $ 4.46 B |